Dicerna Pharma (DRNA) Misses Q3 EPS by 23c
Dicerna Pharma (NASDAQ: DRNA) reported Q3 EPS of ($0.92), $0.23 worse than the analyst estimate of ($0.69).
For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.
Dicerna Pharma (NASDAQ: DRNA) reported Q3 EPS of ($0.92), $0.23 worse than the analyst estimate of ($0.69).
For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.